Teva Pharma is trading 5.8% up at $40.13, with the move appearing more consistent with broader risk-on sentiment than fresh company-specific news. - Teva Pharma closed at $37.93 on August 26, 2026. - No verified positive company-specific catalyst emerged in available coverage. - Recent reporting highlighted a Turkish antitrust investigation into alleged patent and competition practices, which Teva denies.